- Seeds of hope. // Men's Health (10544836);Jul/Aug95, Vol. 10 Issue 6, p96
Reports on the effectiveness of a new option for treating prostate cancer, in which a rice-sized radioactive seed is placed directly in the prostate gland. Safety of the outpatient technique.
- Long-term study becomes benchmark for XRT. Overmyer, Mac // Urology Times;Dec95, Vol. 23 Issue 12, p1
Reports on a long-term study of radical prostatectomy of the Mayo Clinic which provides a benchmark for future studies in the use of external beam radiation therapy (XRT) for prostatic carcinoma. Good prognosis for men aged 60 years or younger presenting with early stage prostate cancer...
- How low should PSA be after radiation therapy for PCa? Bankhead, Charles // Urology Times;Jul96, Vol. 24 Issue 7, p1
Focuses on the use of nadir for long-term recurrence-free survival after irradiation for prostate cancer. Use of a combination of radiotherapy: Threshold of PSA.
- Low pre-Tx PSA may predict adjuvant radiation success. McBroom, Stacy // Urology Times;Mar99, Vol. 27 Issue 3, p13
Reports on a University of Washington, Seattle study which concluded that men who respond to adjuvant radiation therapy for locally recurrent prostate cancer tend to have lower pre-radiation PSA levels and a longer time to biochemical failure following prostatectomy than those not responding to...
- Evolution of toxicity after conformal radiotherapy for prostate cancer. Abdalla, I; Ignacio, L; Vaida, F; Mei-Hsu; Awan, A; Jani, A; Mamo, C; Weichselbaum, R R; Vijayakumar, S // Prostate Cancer & Prostatic Diseases;2002, Vol. 5 Issue 4, p296
The limiting factor for radiation (RT) dose-escalation is normal tissue toxicity. In dose-escalation studies, it is important to determine the factors associated with toxicity and the length of follow-up period after which a particular RT dose is considered safe.We analyzed 449 prostate cancer...
- Potent seeds. // Men's Health;Jul/Aug96, Vol. 11 Issue 6, p106
Reports that outpatient radiation therapy may be as effective at treating prostate cancer as surgery according to doctors at Memorial Sloan-Kettering Cancer Center.
- PSA Elevations After Prostate Cancer Radiotherapy. Kuritzky, Louis // Neurology Alert;Nov2012 Clinical Briefs In Primary Care, p21
The article discusses research by J. M. Crook and colleagues, published in a 2012 issue of the "New England Journal of Medicine" prostate cancer (PCA) recurrences after prostate cancer radiotherapy.
- PERSONAL VIEW. Kelly, W.P. // BMJ: British Medical Journal (International Edition);2/16/91, Vol. 302 Issue 6773, p666
Focuses on the importance of early diagnosis of prostate cancer. Confirmation of the malignancy of cancer; Symptomatic effectiveness of E45 Cream; Efficacy of radiotherapy in inducing edema of prostate cancer.
- Radiotherapy Aids Men with Node-Positive PCa. // Renal & Urology News;Apr2011, Vol. 10 Issue 4, p10
The article reports on the advantages of employing radiotherapy on clinically staged node positive prostate cancer (PCa) patients.
- SBRT Found Suitable for Intermediate-Risk PCa. SCHIESZER, JOHN // Renal & Urology News;Feb2013, Vol. 12 Issue 2, p21
The article reports on the study which revealed that stereotactic body radiotherapy (SBRT) is suitable for intermediate-risk prostate cancer (PCa) in the U.S.